Clinical Trials on Vision in Taiwan
Total 32 results
-
National Taiwan University HospitalUnknown
-
BioGend Therapeutics Co.LtdCompletedChondral or Osteochondral Lesion of Medial Femoral Condyle | Chondral or Osteochondral Lesion of Lateral Femoral Condyle | Chondral or Osteochondral Lesion of TrochleaTaiwan
-
National Taiwan University HospitalTerminatedLumbar Fusion | Lumbar Spinal Fusion SurgeryTaiwan
-
Taipei City HospitalNational Science Council, Taiwan; Taipei Hospital, TaiwanCompleted
-
Taipei Veterans General Hospital, TaiwanCompleted
-
Chung Shan Medical UniversityGrape King Bio Ltd.CompletedCognition Disorders in Old Age | fMRI | Vision | SupplementTaiwan
-
National Taiwan University HospitalRecruiting
-
National Taiwan University HospitalRecruiting
-
National Taiwan University HospitalUnknown
-
Pei-Yuan Lee, MDAeon Biotechnology CorporationUnknownSpinal Fusion | Bone MarrowTaiwan
-
Taipei Veterans General Hospital, TaiwanCompletedReadmission | Lumbar Spinal Fusion | Early DischargeTaiwan
-
National Taiwan University HospitalUnknownPatient With Invasive Cervical Carcinoma | Patient With CIN Lesion | Patient With HPV Infected Patients Without Histopathologic Lesion | Normal Populations.Taiwan
-
Chang Gung UniversityCompletedFatigue | Taiwan-version QuestionnaireTaiwan
-
Far Eastern Memorial HospitalUnknown
-
National Taiwan University HospitalNational Health Research Institutes, TaiwanRecruiting
-
Chang Gung Memorial HospitalUnknown
-
National Yang Ming UniversityTaipei City HospitalUnknown
-
Taipei Veterans General Hospital, TaiwanRecruitingSpinal Stenosis | Spinal Fusion | SpondylolisthesisTaiwan
-
Show Chwan Memorial HospitalCompletedSpinal Fusion | Vitamin D | Lumbar Spine DiseaseTaiwan
-
NovartisCompletedDiabetic Macular EdemaHong Kong, Taiwan, Singapore, Korea, Republic of, China, Japan
-
Taipei Veterans General Hospital, TaiwanCompletedDegenerative Lumbar Spinal Stenosis | Lumbarsacral Orthosis | Transforaminal Lumbar Interbody FusionTaiwan
-
National Taiwan University HospitalRecruitingHelicobacter Pylori Infection | Premalignant LesionTaiwan
-
Novartis PharmaceuticalsCompletedDiabetic Macular EdemaCzechia, India, Russian Federation, Taiwan, Turkey, Lebanon, Denmark, Estonia, France, Germany, Hungary, Korea, Republic of, Latvia, Lithuania, Bulgaria, Norway, Belgium, Malaysia, Sweden, Slovakia, Singapore, Poland, Switzerland
-
National Health Research Institutes, TaiwanCompletedCervical Cancer | Human Papillomavirus | Low-grade Squamous Intraepithelial Lesion,Taiwan
-
Novartis PharmaceuticalsTerminatedBranch Retinal Vein OcclusionChina, Austria, Czechia, Russian Federation, Taiwan, United Kingdom, Canada, Japan, United States, France, Israel, Germany, Italy, Hong Kong, Spain, Denmark, Slovakia, Puerto Rico, Switzerland
-
GuerbetCompletedBlood Brain Barrier Defect | CNS LesionUnited States, Spain, Korea, Republic of, Taiwan, France, Hungary, Belgium, Germany, Italy, Mexico, Poland
-
Merus N.V.RecruitingNSCLC Harboring NRG1 Fusion | Solid Tumours Harboring NRG1 Fusion | Pancreatic Cancer Harboring NRG1 Fusion | NRG1 FusionSpain, France, Israel, Belgium, Denmark, United States, Korea, Republic of, Japan, Germany, Netherlands, Austria, Canada, Italy, Norway, Singapore, Sweden, Taiwan, United Kingdom
-
BayerRecruitingLocally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene FusionUnited States, Austria, Denmark, Germany, Italy, Norway, Spain, United Kingdom, Brazil, Russian Federation, Switzerland, Taiwan, Canada, China, Australia, Greece, Belgium, Sweden, Korea, Republic of, France, Argentina, Finland, Ireland and more
-
BayerActive, not recruitingSolid Tumors Harboring NTRK FusionUnited States, Korea, Republic of, China, Japan, India, France, Turkey, Portugal, Spain, Taiwan, Czechia, Sweden, Brazil, Denmark, Singapore, Argentina, Germany, Ireland
-
Relay Therapeutics, Inc.Active, not recruitingCholangiocarcinoma | Intrahepatic Cholangiocarcinoma | FGFR2 Gene Mutation | FGFR2 Amplification | FGFR2 Gene Fusion/Rearrangement | FGFR2 Gene Translocation | FGFR2 Gene Activation | Other Solid Tumors, AdultUnited States, France, Italy, United Kingdom, Korea, Republic of, Spain, Taiwan, Sweden, Germany, Netherlands, Singapore, Australia, Hong Kong
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
-
Apollomics Inc.RecruitingGastric Cancer | Pancreatic Cancer | NSCLC | Lung Cancer | Brain Tumor | Glioblastoma Multiforme | Advanced Cancer | Colon Cancer | Solid Tumors | Thyroid Cancer | Renal Cancer | Gastroesophageal Junction Adenocarcinoma | EGFR Gene Mutation | MET Amplification | HGF | MET Alteration | MET Fusion | Exon 14 SkippingUnited States, Spain, France, United Kingdom, Taiwan, Australia, Finland, Italy, Singapore, Hungary, Canada, Puerto Rico, Russian Federation